Invitrogen

Influenza A H1N1 NA (A/WSN/1933) Monoclonal Antibody (GT172)

Influenza A H1N1 NA (A/WSN/1933) Antibody in Western Blot (WB)

FIGURE: 1 / 1

Influenza A H1N1 NA (A/WSN/1933) Antibody (MA5-46905) in WB

Western blot analysis of Influenza A H1N1 NA (A/WSN/1933) in whole cell lysate/extract separated by 7.5% SDS-PAGE. Membrane was blotted with Influenza A H1N1 NA (A/WSN/1933) Monoclonal antibody (Product # MA5-46905) using a dilution of 1:5,000. A. 30 µg DF1 whole cell lysate/extract (untreated); B. 30 µg MDA-MB-231 whole cell lysate/extract.

Product Image Gallery

Product Details

MA5-46905

Applications

Tested Dilution

Publications

Western Blot (WB)

1:1,000-1:10,000

Product Specifications

Species Reactivity

Virus

Host/Isotype

Mouse / IgG2b

Class

Monoclonal

Type

Antibody

Clone

GT172

Immunogen

Recombinant protein encompassing a sequence within the Internal region of Influenza A virus H1N1 NA (Neuraminidase) (A/WSN/1933(H1N1). The exact sequence is proprietary.

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1 mg/mL

Purification

Protein G

Storage buffer

PBS

Contains

no preservative

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_2937977

Product Specific Information

Store as concentrated solution.

Centrifuge briefly prior to opening vial.

Positive control: DF1 (WSN infected for 10 hr).

Target Information

Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

References (0)

Have you cited this product in a publication?

Let us know so we can reference it here.

Cite this product

Bioinformatics

Protein Aliases: H1N1 NA; Influenza H1N1

View more View less

Performance Guarantee

If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*

Learn more